Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
AMYPAD holds its General Assembly Meeting
AMYPAD holds its General Assembly Meeting 13 Oct 2021 We were delighted that the event brought together AMYPAD delegates to report on the progress of the project, to exchange ideas and discuss upcoming activities......
Recruitment update
Recruitment update 30 Sep 2021 AMYPAD PHNS: currently 1.097 participants recruited of which 1.052 have been scanned......
Welcome to the 18th issue of the AMYPAD newsletter
Welcome to the 18th issue of the AMYPAD newsletter 03 Sep 2021 September brings everyone back from their holidays so hope you are all suitably rested and ready to go again......
Recruitment status (as 30 September, 2021)
Recruitment status (as 30 September, 2021)